abstract |
The present disclosure relates to inhibitors of zinc-dependent histone deacetylase (HDAC) for use in the treatment of diseases or disorders associated with HDACs such as HDAC6, having the formula I: wherein R, L, X 1 , X 2 , X 3 , X4 , Y1 , Y2 , Y3 , and Y4 are described herein. |